Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Future Oncology (London, England)
|
December 17, 2013
Preclinical and clinical development of afatinib: a focus on breast cancer and squamous cell carcinoma of the head and neck
Nadia Harbeck, Flavio Solca, Thomas C Gauler
Cancer Chemotherapy and Pharmacology
|
April 10, 2014
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
Vassiliki Saloura, Ezra E W Cohen, Lisa Licitra, et al.
Plos One
|
April 22, 2016
Circulating Tumor Cell Composition in Renal Cell Carcinoma
Ivonne Nel, Thomas C Gauler, Kira Bublitz, et al.
Investigational New Drugs
|
October 13, 2011
Phase I open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours
Tanja Trarbach, Beate Schultheis, Thomas C Gauler, et al.
Frontiers in Oncology
|
May 31, 2021
Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab
Michael Pogorzelski, Thomas Hilser, Saskia C Ting, et al.
Plos One
|
January 28, 2014
Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients
Frank Breitenbuecher, Sandra Hoffarth, Karl Worm, et al.
Clinical Lung Cancer
|
July 5, 2014
Assessment of folate receptor-α and epidermal growth factor receptor expression in pemetrexed-treated non-small-cell lung cancer patients
Daniel C Christoph, Bernadette Reyna-Asuncion, Biftu Hassan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 18, 2012
Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed
Daniel C Christoph, Bernadette Reyna Asuncion, Biftu Hassan, et al.
Future Oncology (London, England)
|
May 7, 2014
Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer
Felix Nensa, Jörg Stattaus, Bruno Morgan, et al.
Cancer Immunology, Immunotherapy : CII
|
November 29, 2023
HPV-associated head and neck cancer is characterized by distinct profiles of CD8<sup>+</sup> T cells and myeloid-derived suppressor cells
Benjamin A Kansy, Tim P Wehrs, Kirsten Bruderek, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Future Oncology (London, England)
|
December 17, 2013
Preclinical and clinical development of afatinib: a focus on breast cancer and squamous cell carcinoma of the head and neck
Nadia Harbeck, Flavio Solca, Thomas C Gauler
Cancer Chemotherapy and Pharmacology
|
April 10, 2014
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
Vassiliki Saloura, Ezra E W Cohen, Lisa Licitra, et al.
Plos One
|
April 22, 2016
Circulating Tumor Cell Composition in Renal Cell Carcinoma
Ivonne Nel, Thomas C Gauler, Kira Bublitz, et al.
Investigational New Drugs
|
October 13, 2011
Phase I open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours
Tanja Trarbach, Beate Schultheis, Thomas C Gauler, et al.
Frontiers in Oncology
|
May 31, 2021
Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab
Michael Pogorzelski, Thomas Hilser, Saskia C Ting, et al.
Plos One
|
January 28, 2014
Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients
Frank Breitenbuecher, Sandra Hoffarth, Karl Worm, et al.
Clinical Lung Cancer
|
July 5, 2014
Assessment of folate receptor-α and epidermal growth factor receptor expression in pemetrexed-treated non-small-cell lung cancer patients
Daniel C Christoph, Bernadette Reyna-Asuncion, Biftu Hassan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 18, 2012
Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed
Daniel C Christoph, Bernadette Reyna Asuncion, Biftu Hassan, et al.
Future Oncology (London, England)
|
May 7, 2014
Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer
Felix Nensa, Jörg Stattaus, Bruno Morgan, et al.
Cancer Immunology, Immunotherapy : CII
|
November 29, 2023
HPV-associated head and neck cancer is characterized by distinct profiles of CD8<sup>+</sup> T cells and myeloid-derived suppressor cells
Benjamin A Kansy, Tim P Wehrs, Kirsten Bruderek, et al.
Page
of 2